Walleye Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
12,400
+11,400
+1,140% +$1,000K ﹤0.01% 2059
2026
Q1
$90.4K Sell
1,000
-10,400
-91% -$954K ﹤0.01% 3706
2025
Q4
$1.03M Buy
11,400
+7,200
+171% +$683K ﹤0.01% 2407
2025
Q3
$414K Buy
4,200
+1,500
+56% +$149K ﹤0.01% 2773
2025
Q2
$246K Buy
+2,700
New +$261K ﹤0.01% 3203
2025
Q1
Sell
-15,900
Closed -$1.68M 5260
2024
Q4
$1.68M Buy
15,900
+600
+4% +$64.4K ﹤0.01% 1944
2024
Q3
$1.65M Sell
15,300
-20,700
-58% -$2.26M ﹤0.01% 2150
2024
Q2
$3.91M Buy
36,000
+23,600
+190% +$2.78M 0.01% 1487
2024
Q1
$1.64M Buy
12,400
+7,200
+138% +$899K ﹤0.01% 2149
2023
Q4
$633K Sell
5,200
-5,300
-50% -$591K ﹤0.01% 2756
2023
Q3
$1.18M Buy
10,500
+5,200
+98% +$660K ﹤0.01% 2141
2023
Q2
$772K Buy
+5,300
New +$720K ﹤0.01% 2068
2022
Q4
Sell
-300
Closed -$31K 3696
2022
Q3
$31K Buy
+300
New +$32.9K ﹤0.01% 2669
2020
Q1
Sell
-2,060
Closed -$299K 1774
2019
Q4
$299K Sell
2,060
-7,519
-78% -$1.04M 0.02% 925
2019
Q3
$1.28M Buy
+9,579
New +$1.24M 0.08% 355
2019
Q2
Sell
-3,296
Closed -$409K 2115
2019
Q1
$409K Buy
+3,296
New +$375K 0.07% 460

Other funds holding ZBH

Walleye Capital's ZBH Position: Q2 2026 in Review

Walleye Capital increased its Zimmer Biomet (ZBH) stake by 595% in Q2 2026, buying an estimated $2.84M and bringing the position to 37,861 shares worth $3.26M. The position accounts for 0.01% of the portfolio, ranked #1120.

Walleye Capital first reported a position in ZBH in Q4 2019 and has held it in 14 quarters since. The position peaked at $15.5M in Q3 2023. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Walleye Capital held 37,861 shares of Zimmer Biomet worth $3.26M as of Q2 2026.
  • Walleye Capital bought 32,416 Zimmer Biomet shares in Q2 2026, an estimated $2.84M.
  • Zimmer Biomet made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1120 holding.
  • Walleye Capital first reported a position in Zimmer Biomet in Q4 2019 and has held it in 14 quarters since.
  • Walleye Capital's Zimmer Biomet position peaked at $15.5M in Q3 2023.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.